Comparison of thrombotic adverse events in patients treated with factor VIII products and emicizumab using the 2018-2022 US Food and Drug Administration Adverse Event Reporting System data: comment from Berkowitz et al.
作者信息
Berkowitz Callie, Wilson Samuel, Key Nigel S, Ellsworth Patrick
机构信息
Department of Medicine, Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; University of North Carolina Blood Research Center, Chapel Hill, North Carolina, USA.
Department of Medicine, Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; University of North Carolina Blood Research Center, Chapel Hill, North Carolina, USA.
出版信息
J Thromb Haemost. 2024 Sep;22(9):2674-2675. doi: 10.1016/j.jtha.2024.04.027.
PMID:39174232
Abstract
摘要
Zotero 插件